Cancer of the mammary glands in dogs is very similar to human breast carcinoma. For this reason, treatment methods from human medicine are often used for dogs. Conversely, scientific knowledge gained from canine mammary tumors ...
Jun 6, 2017
0
0
A study recently published in Nature Communications shows that breast cancer cells undergo a stiffening state prior to becoming malignant. The discovery, made by a research team led by Florence Janody, from Instituto Gulbenkian ...
May 16, 2017
0
1
A team of Florida State University researchers is using mathematical modeling to find the best and most effective chemotherapy treatments for cancer patients.
May 2, 2017
0
2
Researchers from the transformation and metastasis group of the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Eva González-Suárez, have recreated and characterized the development of resistance to chemotherapy ...
Apr 27, 2017
0
1
Investigational "hunter" immune cells engineered to seek out and attack a deadly brain cancer known as glioblastoma (GBM) infiltrated patients' tumors and triggered thousands of more T cells once inside, researchers from ...
Apr 10, 2017
0
16
There's a reason why melanoma, the most serious type of skin cancer, is so aggressive. You just need to watch the cells in action.
Apr 3, 2017
0
2
It's not just what's inside breast cancer cells that matters. It's also the environment surrounding cancer cells that drives the disease, according to researchers at the University of North Carolina Lineberger Comprehensive ...
Mar 31, 2017
0
9
An article published in Experimental Biology and Medicine (Volume 242, Issue 6, March, 2017) identifies a new signaling pathway involved in breast cancer cell growth. The study, led by Dr. Chan-Wha Kim, from the Department ...
Mar 30, 2017
0
7
One day, patients may be able to monitor their body's response to cancer therapy just by having their blood drawn. A new study, led by bioengineers at UC Berkeley, has taken an important step in that direction by measuring ...
Mar 24, 2017
0
48
A clinical trial of an antibody-drug conjugate that combines the active portion of a chemotherapy drug with an antibody targeting a molecule expressed on tumor cells appears promising for the treatment of metastatic triple-negative ...
Mar 14, 2017
0
2
